Qcm Cayman, Ltd. Clovis Oncology, Inc. Transaction History

Qcm Cayman, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$3.0 - $16.43 $31,536 - $172,712	-10,512 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$3.93 - $15.35 $41,312 - $161,359	10,512 New	10,512 $41,000
Q1 2018 May 15, 2018	SELL	$50.12 - $67.72 $184,040 - $248,667	-3,672 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$57.69 - $84.58 $211,837 - $310,577	3,672	3,672 $250,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Qcm Cayman, Ltd., based on Form 13F filings with the SEC.

Stay updated on Qcm Cayman, Ltd. with notifications on news.